Wael El-Sayed | Biochemistry | Best Researcher Award

Prof Dr. Wael El-Sayed | Biochemistry | Best Researcher Award

Professor, Faculty of Science – Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Animal Physiology and Toxicology at Ain Shams University, Cairo, Egypt. With over 30 years of experience, he has made significant contributions to physiology, toxicology, and drug development. His research, which spans natural products, drug interactions, and biochemical toxicology, has garnered him a notable academic reputation. Dr. El-Sayed holds an impressive record with 78 articles in international peer-reviewed journals and has been cited over 1,400 times. 🌍📚

 

Publication Profile

 

Strengths for the Award:

  1. Extensive Research Output: Dr. Wael M. El-Sayed has published 78 articles in international peer-reviewed journals, which demonstrates a strong commitment to advancing scientific knowledge in toxicology and physiology.
  2. Impact and Recognition: His work has garnered significant recognition in the scientific community, with a high number of citations across Google Scholar (1462), Scopus (1108), and ResearchGate (1242). His h-index values (22 on Google Scholar, 21 on Scopus, and 20 on ResearchGate) further indicate the influence and relevance of his research.
  3. Diverse Research Platforms: Dr. El-Sayed maintains active profiles on multiple research platforms, including Scopus, ORCID, Web of Science, and ResearchGate, which reflects his engagement with the broader scientific community and his dedication to maintaining visibility and accessibility of his work.
  4. Experience and Expertise: As a Professor of Toxicology and Physiology at a reputable institution (University of Ain Shams), Dr. El-Sayed has significant academic and research experience, further solidifying his expertise in his field.

Areas for Improvement:

  1. Interdisciplinary Collaboration: While Dr. El-Sayed has a strong background in toxicology and physiology, increasing collaboration with researchers in other related fields (e.g., molecular biology, environmental science) could potentially expand the impact and applicability of his research.
  2. Research Funding and Projects: Securing more prominent research grants and leading high-impact projects could further enhance Dr. El-Sayed’s research profile, providing additional resources and opportunities to advance his work.
  3. Global Recognition: While Dr. El-Sayed has significant citations and publications, expanding his research reach through international conferences, collaborations, and workshops could increase his global recognition and further establish him as a leading expert in his field.

 

Education 🎓

Ph.D. in Physiology from Ain Shams University, Egypt, and the University of Utah, USA (2003). Thesis: “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats. “M.Sc. in Physiology from Ain Shams University, Cairo, Egypt (1999). Thesis: “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats. “B.Sc. in Science from Ain Shams University, Cairo, Egypt (1993).

Experience 💼

Professor of Animal Physiology and Toxicology, Zoology Department, Ain Shams University (2014-Present). Associate Professor, Zoology Department, Ain Shams University (2009-2014). Associate Professor, Biology Department, King Faisal University, KSA (2007-2013). Assistant Professor, Zoology Department, Ain Shams University (2003-2009). Post-Doctoral Fellow, Department of Pharmacology and Toxicology, University of Utah (2004-2006). Assistant Lecturer and Demonstrator at Ain Shams University (1994-1999).

Research Focus 🔬

Dr. El-Sayed’s research interests include:

Natural products and their therapeutic effects, Drug-drug interactions and drug metabolism, Chemoprotection and chemoprevention strategies in cancer, Antioxidants and biochemical toxicology, Molecular Biology and Biotechnology

Awards and Honours 🏆

2020: Impact of Zinc Oxide-Sea Lettuce Nanocomposite study funded by STDF. 2018: Novel bithiophenes synthesis and anticancer activity project funded by Mansoura University. 2017: Molecular and biological characterization of recombinant human interferon alpha 2b, funded by STDF.

Publication Top Notes 📑

Ahmed DH, El-Beih NM, El-Hussieny EA, El-Sayed WM. “Large diameter zinc oxide nanoparticles reduced testicular CYP17A1 and viability and elevated testicular inflammation in adult male rats.” Under Review.

EL-Azma MHA, EL-Beih NM, EL-Shamy KA, Koriem KMM, EL-Kassaby MI, EL-Sayed WM. “Pumpkin seed oil exerted antidepressant effects through ameliorating oxidative stress and neuroinflammation in the hippocampus of depressed rats.” Under Review.

Mahmoud MM, El-Batran SA, Hegazy R, El-Sayed WM. “Taurine and enzymatically modified isoquercitrin synergistically protect against methotrexate-induced cardiotoxicity in rats: antioxidant and antiapoptotic effects.” Under Review.

Qasem HH, El-Sayed WM. “The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions.” Under Review.

AbdulKhaliq RJ; Alwandawi1 TK, Al-Hamadani MYI, El-Sayed WM. “Immunological Impact of Vaccination on INF-γ and TNF-α Levels: Gender Disparities and Infection Status Modulation in Iraq Subjects.” Under review.

 

Conclusion:

Dr. Wael M. El-Sayed is a highly qualified candidate for the Best Researcher Award, with a strong research background, significant contributions to his field, and a well-established presence in the scientific community. His extensive publication record and high citation count demonstrate his influence in toxicology and physiology. However, there is potential for further growth through interdisciplinary collaboration, increased research funding, and greater global engagement. Overall, Dr. El-Sayed’s achievements and ongoing contributions make him a compelling candidate for this award.

 

Chloe FERAL | Biochemistry | Best Researcher Award

Chloe FERAL | Biochemistry | Best Researcher Award

Mrs Chloe FERAL, INSERM, France

Based on Mrs. Chloé Féral’s impressive credentials and contributions, she appears to be a highly suitable candidate for the Best Researcher Award.

Publication profile

Orcid

Research Excellence and Achievements

Current Position: Research Director (DR2) at INSERM, France, with significant roles in leading the “Epithelial homeostasis and tumorigenesis” team at IRCAN. Education: Acquired a PhD with honors and Habilitation (HDR), showcasing a strong foundation in Cell and Molecular Pharmacology. Awards and Fellowships: Received prestigious awards such as the Sanofi iAward and multiple grants from INCA and ARC, highlighting her contributions to translational research and cancer studies.

Research Contributions

Publications: Authored numerous high-impact journal articles, including in Scientific Reports, Cell Death & Differentiation, and International Journal of Molecular Sciences. Her research spans critical areas like epithelial homeostasis, tumorigenesis, and cancer biology. Patents: Holds a patent for methods and compositions for treating skin afflictions, demonstrating her innovative approach in research.

Leadership and Impact

Organizational Roles: Organized major scientific meetings and held several institutional responsibilities, such as serving on scientific advisory boards and council boards. Teaching Activity: Actively involved in teaching and training, including lecturing at prestigious institutions like the École Polytechnique Paris.

Scientific Community Engagement

Memberships and Committees: Engaged in various scientific societies and committees, contributing to the evaluation and guidance of research and academic activities.

Notable Research Highlights

Her work on epithelial stem cell fate and tumorigenesis, as well as advancements in cancer research, underlines her role as a leading figure in her field.

Awards

Dr. Chloe FERAL has been recognized for significant contributions in translational research. As Principal Investigator (PI), they led the Sanofi iAward EUROPE for Translational Research (2020-2021) and secured the PL-Bio Grant from INCA (2019-2023), collaborating with a team consortium. They also received the IDEX-UCAJEDI Prematuration grant from the University Côte d’Azur (2019-2020). The Excellency Program from “La Ligue Contre le Cancer” (2014-2018) and the COPOC2018 Inserm Transfert Award (2018) further highlight their achievements. Additionally, Dr. [Name] received ARC Project Awards in 2016-2017 and 2018-2019. 🏆🔬🧬

Publication top notes

The biophysical property of the limbal niche maintains stemness through YAP

Fibroblast growth factor-2 bound to specific dermal fibroblast-derived extracellular vesicles is protected from degradation

Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine

Fibronectin meshwork controls epithelial stem cell fate

Soft limbal niche maintains stem cell compartmentalization and function through YAP

A ganglioside-based senescence-associated immune checkpoint

A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.